Weighted values 2010–2014 | HCV | HBV | NAFLD | ALD | ||||
---|---|---|---|---|---|---|---|---|
International Liver Conference | EASL | AASLD | EASL | AASLD | EASL | AASLD | EASL | AASLD |
Symposia* | 277.5 | 47.5 | 92.5 | 49.5 | 35 | 10 | 25 | 15 |
Titles of sessions† | 144 | 278 | 100 | 164 | 50 | 110 | 42 | 44 |
Oral—general presentations‡ | 78 | 43.5 | 21 | 13.5 | 27 | 6 | 3 | 3 |
Oral—parallel presentations§ | 33 | 54 | 26 | 39 | 13 | 20 | 11 | 16 |
Poster presentation¶ | 945.5 | 1708 | 423.5 | 1135 | 231 | 475.5 | 98.5 | 135 |
Total weighted points | 1478 | 2131 | 663 | 1401 | 356 | 621.5 | 179.5 | 213 |
*Incidence multiplied by 5 research points. It includes courses, joint workshops and industry-supported satellite symposia.
†Incidence multiplied by 4 research points. It includes titles of entire oral parallel session and poster categories.
‡Incidence multiplied by 3 research points. It includes plenary sessions, presidential lectures, state-of-the-art lectures and European Liver Patients Association (ELPA) workshops.
§Incidence multiplied by 2 research points. It includes early morning workshops, meet-the-professor luncheons and grand rounds.
¶Incidence multiplied by 1 research point.
AASLD, American Association for the Study of the Liver; ALD, alcoholic liver disease; EASL, European Association for the Study of Liver Diseases; HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease.